CodeMap® 
150 North Wacker Drive
Suite 2360
Chicago, IL 60606
847-381-5465 Phone
847-381-4606 Fax
customerservice@codemap.com
      


User Information

Create New Account

Lost Password

Username:
Password:


Quick Links

LCDs and LCAs
by Contractor

PLA Codes

Laboratory Fee Schedule

2025
2024
QW Tests

Physician Fee Schedule

2025
2024

OPPS Fee Schedule

2025-January
2024-October

ASC Fee Schedule

2025-January
2024-October

APC Codes

2025-January
2024-October

DRG Codes

2025
2024

ASP Drug Pricing Files

2025-January
2024-October


CMS Transmittals



.


CodeMap® Compliance Briefing: 4/17/09


Editor's Welcome:

Comparative effectiveness (CE) has become a popular buzzword in Washington and may play an important part in healthcare reform efforts. CE studies are designed to compare multiple tests or treatments to determine which is the most effective in terms of clinical outcomes. Due to regulatory constraints, costs may not be considered in a given study. However, tests or procedures that are both cost effective, as well as clinically effective will be the most likely to be included in future treatment guidelines and coverage policy. Today, we will define various aspects of CE studies, the dramatically increased funding now available for such investigations, and the impact these studies may have on Medicare coverage and reim....

Sorry, the full document you are trying to access requires an active subscription.

Please login to the left.


Click here for publications catalog.

--

CodeMap® is a Registered Trademark of Wheaton Partners, LLC.